| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |